As of 2026-02-17, the EV/EBITDA ratio of MacroGenics Inc (MGNX) is -0.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MGNX's latest enterprise value is 28.05 mil USD. MGNX's TTM EBITDA according to its financial statements is -100.24 mil USD. Dividing these 2 quantities gives us the above MGNX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 15.5x | 15.4x |
| Forward P/E multiples | 11.4x - 21.1x | 16.4x |
| Fair Price | (21.20) - (23.33) | (23.89) |
| Upside | -1340.0% - -1464.1% | -1497.0% |
| Date | EV/EBITDA |
| 2026-02-11 | -0.29 |
| 2026-02-10 | -0.28 |
| 2026-02-09 | -0.34 |
| 2026-02-06 | -0.34 |
| 2026-02-05 | -0.27 |
| 2026-02-04 | -0.29 |
| 2026-02-03 | -0.31 |
| 2026-02-02 | -0.31 |
| 2026-01-30 | -0.36 |
| 2026-01-29 | -0.42 |
| 2026-01-28 | -0.34 |
| 2026-01-27 | -0.36 |
| 2026-01-26 | -0.36 |
| 2026-01-23 | -0.34 |
| 2026-01-22 | -0.31 |
| 2026-01-21 | -0.30 |
| 2026-01-20 | -0.31 |
| 2026-01-16 | -0.29 |
| 2026-01-15 | -0.27 |
| 2026-01-14 | -0.32 |
| 2026-01-13 | -0.31 |
| 2026-01-12 | -0.33 |
| 2026-01-09 | -0.36 |
| 2026-01-08 | -0.33 |
| 2026-01-07 | -0.34 |
| 2026-01-06 | -0.27 |
| 2026-01-05 | -0.29 |
| 2026-01-02 | -0.22 |
| 2025-12-31 | -0.22 |
| 2025-12-30 | -0.19 |
| 2025-12-29 | -0.21 |
| 2025-12-26 | -0.22 |
| 2025-12-24 | -0.22 |
| 2025-12-23 | -0.21 |
| 2025-12-22 | -0.20 |
| 2025-12-19 | -0.15 |
| 2025-12-18 | -0.19 |
| 2025-12-17 | -0.22 |
| 2025-12-16 | -0.05 |
| 2025-12-15 | -0.07 |
| 2025-12-12 | -0.08 |
| 2025-12-11 | -0.09 |
| 2025-12-10 | -0.08 |
| 2025-12-09 | -0.08 |
| 2025-12-08 | -0.04 |
| 2025-12-05 | -0.07 |
| 2025-12-04 | -0.07 |
| 2025-12-03 | -0.08 |
| 2025-12-02 | -0.10 |
| 2025-12-01 | -0.12 |